C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China
· Delayed Price · Currency is CNY 4.940
+0.010 (0.20%)
May 23, 2025, 2:45 PM CST
SHE:000950 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 401.79 | 654.96 | 952.28 | 1,005 | 884.34 | Upgrade
|
| Depreciation & Amortization | 465.72 | 375.18 | 403.9 | 312.62 | 124.75 | Upgrade
|
| Other Amortization | 76.8 | 70.14 | 33.17 | 37.51 | 26.58 | Upgrade
|
| Loss (Gain) From Sale of Assets | -10.53 | -0.79 | -10.05 | -3.52 | -21.62 | Upgrade
|
| Asset Writedown & Restructuring Costs | 83.04 | 20.49 | 27.93 | 10.67 | 14.76 | Upgrade
|
| Loss (Gain) From Sale of Investments | -402.41 | -317.71 | -305.8 | -429.57 | -301.22 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 388.33 | 124.48 | 282.22 | 101.09 | Upgrade
|
| Other Operating Activities | 1,662 | 1,517 | 1,336 | 1,053 | 788.23 | Upgrade
|
| Change in Accounts Receivable | -1,663 | -6,037 | -3,878 | -3,989 | -2,343 | Upgrade
|
| Change in Inventory | -1,432 | -73.98 | -1,824 | -185.46 | -51.37 | Upgrade
|
| Change in Accounts Payable | 728.6 | 4,007 | 3,401 | 2,183 | 1,439 | Upgrade
|
| Operating Cash Flow | -186.74 | 508.53 | 285.83 | 250.16 | 631.99 | Upgrade
|
| Operating Cash Flow Growth | - | 77.92% | 14.26% | -60.42% | 212.23% | Upgrade
|
| Capital Expenditures | -250.53 | -244.41 | -268.07 | -489.55 | -378.16 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.4 | 0.83 | 6.59 | 11.65 | 27.56 | Upgrade
|
| Cash Acquisitions | -138.36 | -187.75 | -226.86 | -650.59 | -1,491 | Upgrade
|
| Divestitures | - | -28.9 | 81.85 | 33.3 | - | Upgrade
|
| Investment in Securities | 41.04 | 68.49 | 168.16 | -39.84 | -185.95 | Upgrade
|
| Other Investing Activities | 163.99 | 24.94 | 47.09 | 165.52 | 41.04 | Upgrade
|
| Investing Cash Flow | -182.46 | -358.38 | -191.24 | -969.51 | -1,957 | Upgrade
|
| Long-Term Debt Issued | 23,784 | 25,555 | 24,481 | 28,019 | 22,651 | Upgrade
|
| Long-Term Debt Repaid | -22,903 | -26,513 | -21,746 | -24,862 | -20,440 | Upgrade
|
| Net Debt Issued (Repaid) | 880.82 | -958.02 | 2,735 | 3,157 | 2,211 | Upgrade
|
| Issuance of Common Stock | - | - | - | 41.9 | - | Upgrade
|
| Common Dividends Paid | -1,120 | -1,299 | -928.81 | -1,227 | -664.92 | Upgrade
|
| Other Financing Activities | 287.6 | 2,510 | -626.11 | -429.17 | 81.35 | Upgrade
|
| Financing Cash Flow | 48.33 | 252.49 | 1,180 | 1,542 | 1,627 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | -0.12 | -0.01 | Upgrade
|
| Net Cash Flow | -320.87 | 402.64 | 1,274 | 822.74 | 301.83 | Upgrade
|
| Free Cash Flow | -437.27 | 264.13 | 17.76 | -239.38 | 253.82 | Upgrade
|
| Free Cash Flow Growth | - | 1386.93% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -0.54% | 0.33% | 0.03% | -0.38% | 0.56% | Upgrade
|
| Free Cash Flow Per Share | -0.25 | 0.15 | 0.01 | -0.14 | 0.15 | Upgrade
|
| Cash Income Tax Paid | 1,438 | 1,755 | 1,384 | 1,351 | 983.63 | Upgrade
|
| Levered Free Cash Flow | 553.06 | 1,209 | -2,481 | -3,830 | -5,510 | Upgrade
|
| Unlevered Free Cash Flow | 553.06 | 2,047 | -1,778 | -3,139 | -5,087 | Upgrade
|
| Change in Net Working Capital | 889.58 | -596.82 | 3,308 | 4,360 | 5,962 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.